Denna sida har översatts automatiskt och översättningens korrekthet kan inte garanteras. Vänligen se engelsk version för en källtext.

Whole-Body Cryotherapy and Isokinetic Performance After Exercise-Induced Fatigue (WBC-ISO)

1 juni 2026 uppdaterad av: Zeynep Koluman, Biruni University

Effect of Whole-Body Cryotherapy on Isokinetic Performance After Exercise-Induced Fatigue

This randomized crossover study investigated the effects of whole-body cryotherapy (WBC) on isokinetic knee performance following running-induced fatigue in physically active healthy male university students. Participants completed two recovery conditions, WBC and passive rest, on separate days following a standardized treadmill fatigue protocol. Knee extension and flexion strength were assessed using an isokinetic dynamometer at angular velocities of 60°/s and 240°/s. In addition, blood pressure, heart rate, oxygen saturation, and perceived fatigue responses were monitored throughout the recovery period. The study aimed to determine whether WBC improves post-exercise recovery and lower-extremity muscle performance compared with passive rest.

Studieöversikt

Status

Avslutad

Intervention / Behandling

Detaljerad beskrivning

This study was designed to investigate the effects of whole-body cryotherapy (WBC) on recovery and isokinetic muscle performance following exercise-induced fatigue in physically active healthy male university students. Exercise-induced fatigue is associated with reduced muscle force production, impaired performance, and increased injury risk. Various recovery strategies have been used to minimize these negative effects, and WBC has gained increasing attention in sports medicine because of its potential physiological and neuromuscular recovery benefits.

The study used a randomized within-subject crossover design in which participants completed two recovery conditions, WBC and passive rest, on separate days following a standardized treadmill-based fatigue protocol. During the WBC condition, participants were exposed to a two-stage cryogenic chamber consisting of an adaptation chamber at -30°C followed by a main chamber at -85°C. Passive rest sessions were performed under the same laboratory conditions without cryotherapy exposure.

Primary outcome measures included isokinetic knee extension and flexion performance assessed at angular velocities of 60°/s and 240°/s using an isokinetic dynamometer. Peak torque and body mass-normalized peak torque values were analyzed for both dominant and non-dominant lower extremities. Secondary outcome measures included systolic and diastolic blood pressure, heart rate, oxygen saturation, and perceived fatigue responses measured throughout the recovery period.

The aim of the study was to determine whether WBC provides superior recovery effects compared with passive rest following running-induced acute fatigue.

Studietyp

Interventionell

Inskrivning (Faktisk)

30

Fas

  • Inte tillämpbar

Kontakter och platser

Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.

Studieorter

    • Istanbul
      • Istanbul, Istanbul, Turkiet (Türkiye), 34000
        • Istanbul University

Deltagandekriterier

Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.

Urvalskriterier

Åldrar som är berättigade till studier

  • Vuxen

Tar emot friska volontärer

Ja

Beskrivning

Inclusion Criteria:

  • Healthy male participants aged 18-30 years with no exercise limitation
  • No history of knee or lower-extremity injury requiring physiotherapy or surgical intervention
  • No current lower-extremity pain
  • No limitation in lower-extremity range of motion
  • No chronic disease
  • No mental or psychological disorder

Exclusion Criteria:

  • Presence of cardiovascular disease
  • Presence of respiratory disease
  • History of cold allergy
  • Presence of a tumor-related disease
  • Presence of a viral or bacterial infection
  • Diagnosis of Raynaud's disease
  • Presence of claustrophobia

Studieplan

Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.

Hur är studien utformad?

Designdetaljer

  • Primärt syfte: Grundläggande vetenskap
  • Tilldelning: Randomiserad
  • Interventionsmodell: Crossover tilldelning
  • Maskning: Ingen (Open Label)

Vapen och interventioner

Deltagargrupp / Arm
Intervention / Behandling
Experimentell: Whole-Body Cryotherapy
Participants underwent whole-body cryotherapy following the running-induced fatigue protocol.
Participants underwent whole-body cryotherapy following a standardized running-induced fatigue protocol. The intervention was performed in a two-stage cryogenic chamber consisting of a 30-second adaptation phase at -30°C followed by a 3-minute exposure at -85°C.
Inget ingripande: Passive Rest
Participants completed passive seated rest following the running-induced fatigue protocol.

Vad mäter studien?

Primära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Peak Torque During Knee Extension and Flexion
Tidsram: Immediately after the 30-minute recovery period
Assessment of isokinetic knee extension and flexion peak torque at 60°/s and 240°/s following whole-body cryotherapy and passive rest recovery conditions.
Immediately after the 30-minute recovery period
Peak Torque Normalized to Body Mass
Tidsram: Immediately after the 30-minute recovery period
Assessment of body mass-normalized peak torque values during isokinetic knee extension and flexion testing at 60°/s and 240°/s.
Immediately after the 30-minute recovery period

Sekundära resultatmått

Resultatmått
Åtgärdsbeskrivning
Tidsram
Heart Rate
Tidsram: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
Assessment of heart rate responses throughout the recovery period following exercise-induced fatigue.
Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
Blood Pressure
Tidsram: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
Assessment of systolic and diastolic blood pressure responses throughout the recovery period.
Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
Oxygen Saturation
Tidsram: Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
Assessment of peripheral oxygen saturation during the recovery period.
Baseline, immediately after exercise, and every 5 minutes during the 30-minute recovery period
Perceived Fatigue
Tidsram: Immediately after exercise, 5 minutes, and 10 minutes after exercise
Assessment of perceived fatigue using the Borg Rating of Perceived Exertion (RPE) Scale (6-20 points). Scores range from 6 (no exertion) to 20 (maximal exertion), with higher scores indicating greater perceived fatigue and exertion.
Immediately after exercise, 5 minutes, and 10 minutes after exercise

Samarbetspartners och utredare

Det är här du hittar personer och organisationer som är involverade i denna studie.

Publikationer och användbara länkar

Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.

Studieavstämningsdatum

Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.

Studera stora datum

Studiestart (Faktisk)

2 september 2024

Primärt slutförande (Faktisk)

1 maj 2025

Avslutad studie (Faktisk)

1 maj 2025

Studieregistreringsdatum

Först inskickad

24 maj 2026

Först inskickad som uppfyllde QC-kriterierna

24 maj 2026

Första postat (Faktisk)

1 juni 2026

Uppdateringar av studier

Senaste uppdatering publicerad (Faktisk)

2 juni 2026

Senaste inskickade uppdateringen som uppfyllde QC-kriterierna

1 juni 2026

Senast verifierad

1 maj 2026

Mer information

Termer relaterade till denna studie

Plan för individuella deltagardata (IPD)

Planerar du att dela individuella deltagardata (IPD)?

NEJ

Läkemedels- och apparatinformation, studiedokument

Studerar en amerikansk FDA-reglerad läkemedelsprodukt

Nej

Studerar en amerikansk FDA-reglerad produktprodukt

Nej

Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .

Prenumerera